Molecular Docking and QSAR Study of 2-Benzoxazolinone, Quinazoline and Diazocoumarin Derivatives as Anti-HIV-1 Agents

AuthorKamyar Faghihien
AuthorMahdieh Safakishen
AuthorTannaz Zebardasten
AuthorZahra Hajimahdien
AuthorAfshin Zarghien
Issued Date2019-07-31en
AbstractA series of 2-benzoxazolinone, diazocoumarin and quinazoline derivatives have been shown to inhibit HIV replication in cell culture. To understand the pharmacophore properties of selected molecules and design new anti-HIV agents, quantitative structure–activity relationship (QSAR) study was developed using a descriptor selection approach based on the stepwise method. Multiple linear regression method was applied to relate the anti-HIV activities of dataset molecules to the selected descriptors. Obtained QSAR model was statistically significant with correlation coefficient R2 of 0.84 and leave one out coefficient Q2 of 0.73. The model was validated by test set molecules giving satisfactory prediction value (R2test) of 0.79. Molecules also were docked on HIV integrase enzyme and showed important interactions with the key residues in enzyme active site. These data might be helpful for design and discovery of novel anti-HIV compounds.en
DOIhttps://doi.org/10.22037/ijpr.2019.1100746en
KeywordAnti-HIVen
KeywordDockingen
KeywordQSARen
KeywordMultiple linear regressionsen
KeywordStepwiseen
PublisherBrieflandsen
TitleMolecular Docking and QSAR Study of 2-Benzoxazolinone, Quinazoline and Diazocoumarin Derivatives as Anti-HIV-1 Agentsen
TypeOriginal Articleen

Files